Nvidia-Backed AI Drug Discovery Company Iambic Therapeutics Files for Nasdaq IPO, to Use Proceeds for Cancer Drug Development

Here's How Many Shares of AbbVie You'd Need for $5,000 in Yearly Dividends

AbbVie, a Dividend King with 53 consecutive years of dividend increases, would require 723 shares (approximately $206,358) to generate $5,000 in annual dividends at its current price. Despite a modest 2.4% forward yield, the pharmaceutical giant's strong portfolio of blockbuster drugs, low P/E ratio of 16, and 93% stock rally over three years make it an attractive long-term income investment, even compared to higher-yielding alternatives like Pfizer.

Live On CNBC, Kevin Simpson Announces Bought AbbVie

GE Aerospace Stock Nears Death Cross Amid Valuation Concerns and Strong Earnings Outlook

GE Aerospace stock is nearing a death cross amid the ongoing valuation concerns ahead of its third quarter earnings report.

Nvidia Enters Correction After Rising Wedge Breakdown as AI Stock Bubble Index Jumps

Nvidia stock has dropped and moved into a technical correction after moving below the lower side of the rising wedge as the ai stock bubble jumps.

iPhone Duo Preorders, AAPL Crosses $5 Trillion and More: This Week in Appleverse

Apple dominates headlines as iPhone Duo preorders surge, shares rise, market value tops $5 trillion and China AI launch plans emerge.

Inflation Shakes Fed Outlook Crude Oil Surges, Sanders Targets Oil Companies and More: This Week in Economy

Inflation rattles Fed expectations as AI valuations, rising fuel costs, oil taxes and bond yields fuel fresh market concerns.